Assembly Biosciences ASMB Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's stock issuance proceeds?
- Assembly Biosciences (ASMB) reported stock issuance proceeds of $0 in Q1 2026.
- How has Assembly Biosciences's stock issuance proceeds changed year-over-year?
- Assembly Biosciences's stock issuance proceeds decreased by 100.0% year-over-year, from $1.92M to $0.
- What is the long-term trend for Assembly Biosciences's stock issuance proceeds?
- Over 2 years (2021 to 2024), Assembly Biosciences's stock issuance proceeds has grown at a -80.4% compound annual growth rate (CAGR), from $52.81M to $2.03M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.